Nanostructured lipid carriers: A potential use for skin drug delivery systems

被引:101
作者
Czajkowska-Kosnik, Anna [1 ]
Szekalska, Marta [1 ]
Winnicka, Katarzyna [1 ]
机构
[1] Med Univ Bialystok, Dept Pharmaceut Technol, Bialystok, Poland
关键词
Nanostructured lipid carriers; Skin delivery; Permeation enhancer; IN-VIVO EVALUATION; TRANSDERMAL DELIVERY; CONTROLLED-RELEASE; ORAL BIOAVAILABILITY; TOPICAL DELIVERY; NANOPARTICLES SLN; NLC FORMULATION; STRATUM-CORNEUM; VITRO; IRRITATION;
D O I
10.1016/j.pharep.2018.10.008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Skin application of pharmaceutical products is one of the methods used for drug administration. The problem of limited drug penetration via topical application makes searching for safe drug carriers that will provide an expected therapeutic effect of utmost importance. Research into safe drug carriers began with liposome structures, paving the way for work with nanocarriers, which currently play a large role as drug vehicles. Nanostructured lipid carriers (NLC) consist of blended solid and liquid lipids (oils) dispersed in an aqueous solution containing a surfactant. These carriers have many advantages: good biocompatibility, low cytotoxicity, high drug content; they enhance a drug's stability and have many possibilities of application (oral, intravenous, pulmonary, ocular, dermal). The following article presents properties, methods of preparation and tests to assess the quality and toxicity of NLC. This analysis indicates the possibility of using NLC for dermal and transdermal drug application. (C) 2018 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:156 / 166
页数:11
相关论文
共 149 条
[1]  
Ahad M.A. A., 2010, ASIAN J PHARM SCI, V5, P276
[2]   Nanostructured Lipid Carrier for Topical Application of N-Acetyl Glucosamine [J].
Aliasgharlou, Lavin ;
Ghanbarzadeh, Saeed ;
Azimi, Hamideh ;
Zarrintan, Mohammad Hossein ;
Hamishehkar, Hamed .
ADVANCED PHARMACEUTICAL BULLETIN, 2016, 6 (04) :581-587
[3]   Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum [J].
Alkilani, Ahlam Zaid ;
McCrudden, Maeliosa T. C. ;
Donnelly, Ryan F. .
PHARMACEUTICS, 2015, 7 (04) :438-470
[4]  
Ananthapadmanabhan K. P., 2003, International Journal of Cosmetic Science, V25, P103, DOI 10.1046/j.1467-2494.2003.00176.x
[5]   CHEMICAL AND PHARMACOLOGICAL SKIN IRRITATION IN MAN - A REFLECTANCE SPECTROSCOPIC STUDY [J].
ANDERSEN, PH ;
NANGIA, A ;
BJERRING, P ;
MAIBACH, HI .
CONTACT DERMATITIS, 1991, 25 (05) :283-289
[6]  
[Anonymous], 2012, No. 305: Bioaccumulation in Fish: Aqueous and Dietary Exposure.In OECD Guidelines for Testing of Chemicals
[7]   Sustained Release and Permeation of Timolol from Surface-Modified Solid Lipid Nanoparticles through Bioengineered Human Cornea [J].
Attama, A. A. ;
Reichl, S. ;
Mueller-Goymann, C. C. .
CURRENT EYE RESEARCH, 2009, 34 (08) :698-705
[8]   The Impact of Variables on Particle Size of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers; A Comparative Literature Review [J].
Bahari, Leila Azhar Shekoufeh ;
Hamishehkar, Hamed .
ADVANCED PHARMACEUTICAL BULLETIN, 2016, 6 (02) :143-151
[9]   NEGATIVE STAINING OF PHOSPHOLIPIDS + THEIR STRUCTURAL MODIFICATION BY-SURFACE ACTIVE AGENTS AS OBSERVED IN ELECTRON MICROSCOPE [J].
BANGHAM, AD ;
HORNE, RW .
JOURNAL OF MOLECULAR BIOLOGY, 1964, 8 (05) :660-&
[10]   Transdermal Drug Delivery In Vitro Using Diffusion Cells [J].
Bartosova, L. ;
Bajgar, J. .
CURRENT MEDICINAL CHEMISTRY, 2012, 19 (27) :4671-4677